The emerging role of WISP proteins in tumorigenesis and cancer therapy

被引:0
作者
Yi Liu
Yizuo Song
Miaomiao Ye
Xiaoli Hu
Z. Peter Wang
Xueqiong Zhu
机构
[1] The Second Affiliated Hospital of Wenzhou Medical University,Department of Obstetrics and Gynecology
[2] The Second Affiliated Hospital of Wenzhou Medical University,Center of Scientific Research
[3] Bengbu Medical College,Department of Biochemistry and Molecular Biology, School of Laboratory Medicine
[4] Beth Israel Deaconess Medical Center,Department of Pathology
[5] Harvard Medical School,undefined
来源
Journal of Translational Medicine | / 17卷
关键词
Cancer; WISP; Oncogene; Drug; Targets; Therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Accumulated evidence has demonstrated that WNT1 inducible signaling pathway protein (WISP) genes, which belong to members of the CCN growth factor family, play a pivotal role in tumorigenesis and progression of a broad spectrum of human cancers. Mounting studies have identified that WISP proteins (WISP1-3) exert different biological functions in various human malignancies. Emerging evidence indicates that WISP proteins are critically involved in cell proliferation, apoptosis, invasion and metastasis in cancers. Because the understanding of a direct function of WISP proteins in cancer development and progression has begun to emerge, in this review article, we describe the physiological function of WISP proteins in a variety of human cancers. Moreover, we highlight the current understanding of how the WISP protein is involved in tumorigenesis and cancer progression. Furthermore, we discuss that targeting WISP proteins could be a promising strategy for the treatment of human cancers. Hence, the regulation of WISP proteins could improve treatments for cancer patients.
引用
收藏
相关论文
共 557 条
[41]  
Poorhosseini SM(2016)HBx mutations promote hepatoma cell migration through the Wnt/beta-catenin signaling pathway Cancer Sci 107 1380-49847
[42]  
Inadera H(2013)WNT signalling pathways as therapeutic targets in cancer Nat Rev Cancer 13 11-152
[43]  
Hashimoto S(2014)Can we safely target the WNT pathway? Nat Rev Drug Discov. 13 513-933
[44]  
Dong HY(2013)Upregulation of T-cell factor-4 isoform-responsive target genes in hepatocellular carcinoma Liver Int. 33 1100-4473
[45]  
Suzuki T(2001)COL11A1 in FAP polyps and in sporadic colorectal tumors BMC Cancer. 1 17-1564
[46]  
Nagai S(2006)Effect of indomethacin on Bfl-1, WISP-1 and proliferating cell nuclear antigen in colon cancer cell line HCT116 cells Chin J Dig Dis. 7 219-6461
[47]  
Yamashita T(2015)Overexpression of DHX32 contributes to the growth and metastasis of colorectal cancer Sci Rep. 5 9247-269
[48]  
Inadera H(2016)High expression of WISP1 in colon cancer is associated with apoptosis, invasion and poor prognosis Oncotarget. 7 49834-504
[49]  
Dong HY(2016)Frameshift mutation of WISP3 gene and its regional heterogeneity in gastric and colorectal cancers Hum Pathol 50 146-70
[50]  
Matsushima K(2017)Association of Wnt1-inducible signaling pathway protein-1 with the proliferation, migration and invasion in gastric cancer cells Tumour Biol 39 1010428317699755-522